1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow SoC Treatment: new trials by email Literature Review of SoC Treatment trials Research Report on SoC Treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors mRNA-4157, Pembrolizumab, SoC Treatment - Solid Tumors | Phase 1 | Active not recruiting | ModernaTX, Inc. | 161 | 2017-08-14 | 2026-09-03 |
ModernaTX, Inc. (1)
Australia (1) · Japan (1) · United Kingdom (1) · United States (1)
2023 (1)